Search Results 1421-1430 of 17458 for corticosteroid

1. Valrubicin (Intravesical Route) Description and Brand Names - Mayo Clinic

   Valrubicin is used as a solution that is run through a tube (instilled through a catheter) into the bladder to treat bladder cancer.

2. A Study to Evaluate the Effectiveness of Nicotinamide Riboside and Pterostilbene Treatment to Protect the Kidneys in Patients with Complex Aortic Aneurysm Repair and Aortic Arch Reconstruction - Mayo Clinic

   Patients taking any immunosuppressant, except for corticosteroids. Patients taking any of these well-known P-glycoprotein substrates: digoxin, fexofenadine ...

3. A Study to Evaluate Individualized Lifestyle Intervention for Obesity Management Based on Obesity Phenotypes - Mayo Clinic

   Current use of anti-obesity pharmacotherapy, medications known to affect weight (e.g., corticosteroids) or GLP-1 agonist/analog for T2DM. A positive score ...

4. Roflumilast (topical application route) - Mayo Clinic

   Roflumilast topical cream is used to treat plaque psoriasis, which is a form of skin disease with red patches and white scales that do not go away. It is also ...

5. Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure - Mayo Clinic

   The purpose of this study is to evaluate different strategies of cardiovascular therapy with Carvedilol, aiming to reduce the incidence of left ventricular ...

6. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

   ... corticosteroids > 10 mg/day prednisone or equivalent, or growth factor treatment (e.g., erythropoietin), hormones (e.g., androgens, danazol) ≤ 14 days ...

7. Consumer health Integrative medicine - Mayo Clinic

   Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...

8. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Efficacy and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI Investigational eFlow® Device plus Standard of Care versus Standard of Care Alone in the Treatment of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome in Patients post Single Lung Transplantation - Mayo Clinic

   systemic corticosteroid such as prednisone as third agent. The regimen must be stable within 4 weeks prior to randomization with respect to the therapeutic ...

9. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

   Patients previously treated or untreated for brain metastases that are asymptomatic in the absence of corticosteroid therapy or on a stable dose of steroids ...

10. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    Prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy; A prior/recent short course (< 2 weeks) ...